Current Advances in Immunotherapy for Glioblastoma Multiforme and Future Prospects
Author:
Publisher
Cureus, Inc.
Subject
Aerospace Engineering
Reference66 articles.
1. Advances in immunotherapy for glioblastoma multiforme;Huang B;J Immunol Res,2017
2. Glioblastoma multiforme: a review of its epidemiology and pathogenesis through clinical presentation and treatment;Hanif F;Asian Pac J Cancer Prev,2017
3. Current advances in immunotherapy for glioblastoma;Mende AL;Curr Oncol Rep,2021
4. Effect of nivolumab vs bevacizumab in patients with recurrent glioblastoma: the CheckMate 143 phase 3 randomized clinical trial;Reardon DA;JAMA Oncol,2020
5. Viral and other therapies for recurrent glioblastoma: is a 24-month durable response unusual?;Chiocca EA;Neuro Oncol,2019
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Nanotechnology Meets Stem Cell Therapy for Treating Glioblastomas: A Review;ACS Applied Nano Materials;2024-01-22
2. Upregulation of the canonical signaling pathway of interferon-gamma is associated with glioblastoma progression;Molecular Biology Reports;2024-01-03
3. Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements;International Journal of Molecular Sciences;2023-10-10
4. Navigating the Immune Challenge in Glioblastoma: Exploring Immunotherapeutic Avenues for Overcoming Immune Suppression;Cureus;2023-09-27
5. Immunotherapy in glioblastoma treatment: Current state and future prospects;World Journal of Clinical Oncology;2023-04-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3